Whether or not there are polymorphisms within androgen-receptor genes that differ between men and women, the differences in COVID-19 outcome by sex are more likely directly related to the availability of the androgenic ligand to its receptor, depending on the circulating levels of the ligand and potentially to the various modifiers [9]. This evidence concerns the gene AR and COVID-19.